Publisher： Bentham Science Publishers
E-ISSN： 2212-3970|1|3|397-403
ISSN： 1574-8928
Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.1, Iss.3, 2006-11, pp. : 397-403
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The Role of Bortezomib in the Treatment of Lymphoma
By Barr Paul Fisher Richard Friedberg Jonathan
Cancer Investigation, Vol. 25, Iss. 8, 2007-11 ,pp. :
Bortezomib inhibits cell proliferation in prostate cancer
Experimental and Therapeutic Medicine, Vol. 10, Iss. 3, 2015-01 ,pp. :
Plasma cell leukemia: advantages of treatment with bortezomib
By Fraimout N.
Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. :